These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 14962486

  • 1. The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction.
    Tschöpe C, Spillmann F, Altmann C, Koch M, Westermann D, Dhayat N, Dhayat S, Bascands JL, Gera L, Hoffmann S, Schultheiss HP, Walther T.
    Cardiovasc Res; 2004 Feb 15; 61(3):559-69. PubMed ID: 14962486
    [Abstract] [Full Text] [Related]

  • 2. Effects of a novel bradykinin B1 receptor antagonist and angiotensin II receptor blockade on experimental myocardial infarction in rats.
    Wu D, Lin X, Bernloehr C, Hildebrandt T, Doods H.
    PLoS One; 2012 Feb 15; 7(12):e51151. PubMed ID: 23236443
    [Abstract] [Full Text] [Related]

  • 3. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
    Walther T, Siems WE, Hauke D, Spillmann F, Dendorfer A, Krause W, Schultheiss HP, Tschöpe C.
    FASEB J; 2002 Aug 15; 16(10):1237-41. PubMed ID: 12153991
    [Abstract] [Full Text] [Related]

  • 4. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D, Galuppo P, Schmidt I, Ertl G, Bauersachs J.
    Cardiovasc Res; 2005 Jul 01; 67(1):97-105. PubMed ID: 15949473
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Upregulation of bradykinin B1-receptor expression after myocardial infarction.
    Tschöpe C, Heringer-Walther S, Koch M, Spillmann F, Wendorf M, Leitner E, Schultheiss HP, Walther T.
    Br J Pharmacol; 2000 Apr 01; 129(8):1537-8. PubMed ID: 10780955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle.
    Ambrose J, Pribnow DG, Giraud GD, Perkins KD, Muldoon L, Greenberg BH.
    J Cardiovasc Pharmacol; 1999 Mar 01; 33(3):433-9. PubMed ID: 10069680
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
    Jugdutt BI, Menon V.
    J Cardiovasc Pharmacol Ther; 2003 Sep 01; 8(3):217-26. PubMed ID: 14506547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.
    Nguyen QT, Colombo F, Clement R, Gosselin H, Rouleau JL, Calderone A.
    Br J Pharmacol; 2003 Apr 01; 138(8):1485-94. PubMed ID: 12721104
    [Abstract] [Full Text] [Related]

  • 13. Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction.
    Tschöpe C, Heringer-Walther S, Koch M, Spillmann F, Wendorf M, Hauke D, Bader M, Schultheiss HP, Walther T.
    J Hypertens; 2000 Feb 01; 18(2):223-8. PubMed ID: 10694192
    [Abstract] [Full Text] [Related]

  • 14. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
    Sen S, Kanter M, Ustundag S, Aktas C, Dogutan H, Yalcin O.
    Ren Fail; 2008 Feb 01; 30(10):1023-33. PubMed ID: 19016156
    [Abstract] [Full Text] [Related]

  • 15. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM.
    Clin Sci (Lond); 2012 Dec 01; 123(11):649-58. PubMed ID: 22715807
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema.
    Austinat M, Braeuninger S, Pesquero JB, Brede M, Bader M, Stoll G, Renné T, Kleinschnitz C.
    Stroke; 2009 Jan 01; 40(1):285-93. PubMed ID: 18988906
    [Abstract] [Full Text] [Related]

  • 18. Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors.
    Rodrigues ES, Silva RF, Martin RP, Oliveira SM, Nakaie CR, Sabatini RA, Merino VF, Pesquero JB, Bader M, Shimuta SI.
    Peptides; 2013 Apr 01; 42():1-7. PubMed ID: 23306173
    [Abstract] [Full Text] [Related]

  • 19. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY, Huang YL, Sun YH.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 20; 85(15):1053-6. PubMed ID: 16029550
    [Abstract] [Full Text] [Related]

  • 20. [On angiotensin II receptor distribution after myocardial infarction in dogs].
    Qu XF, Li JJ, Xi Y, Shen JX, Xiu CH, Yue L, Wang GZ, Huang YL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr 20; 37(4):358-62. PubMed ID: 19791474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.